These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 768774)

  • 21. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
    Rada EM; Convit J; Ulrich M; Gallinotto ME; Aranzazu N
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test.
    Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.
    Myrvang B; Godal T; Ridley DS; Fröland SS; Song YK
    Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstrain variations of resistance and delayed type hypersensitivity in mice after infection with various substrains of Mycobacterium bovis (strains BCG) and after immunization with Mycobacterium leprae.
    Lagrange PH
    Trop Med Parasitol; 1990 Sep; 41(3):304-6. PubMed ID: 2255850
    [No Abstract]   [Full Text] [Related]  

  • 25. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients.
    Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T
    Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of purified protein derivative and sonicates of Mycobacterium leprae and Mycobacterium bovis BCG on thromboplastin response in human monocytes in vitro.
    Lyberg T; Closs O; Prydz H
    Infect Immun; 1982 Dec; 38(3):855-9. PubMed ID: 6185426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium bovis BCG but not Mycobacterium leprae induces TNF-alpha secretion in human monocytic THP-1 cells.
    Oliveira MM; Charlab R; Pessolani MC
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):973-8. PubMed ID: 11685264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen.
    Adams E; Britton WJ; Morgan A; Goodsall AL; Basten A
    Clin Exp Immunol; 1993 Dec; 94(3):500-6. PubMed ID: 7504601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cellular and molecular basis of immunity against mycobacterial diseases.
    Colston MJ
    Soc Appl Bacteriol Symp Ser; 1996; 25():33S-39S. PubMed ID: 8972118
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin-2-induced T-cell response to M. leprae in lepromatous leprosy: reversion of a suppressor mechanism or expansion of a small M. leprae-reactive T-cell pool?
    Shankar P; Wallach D; Bach MA
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):649-52. PubMed ID: 2935587
    [No Abstract]   [Full Text] [Related]  

  • 32. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limiting dilution analysis in leprosy.
    Mullins RJ; Roche P; Adams E; Jones P; Chen S; Theuvenet W; Basten A
    Immunol Cell Biol; 1992 Aug; 70 ( Pt 4)():277-90. PubMed ID: 1427986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacterium leprae.
    Harris DP; Vordermeier HM; Roman E; Lathigra R; Brett SJ; Moreno C; Ivanyi J
    J Immunol; 1991 Oct; 147(8):2706-12. PubMed ID: 1717575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity to leprosy. III. The in vitro induction of B lymphocyte proliferation by mycobacteria.
    Douglas-Jones AG; Wade S; Kent D; Vaughan R; Watson JD
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):63-70. PubMed ID: 3086467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro stimulation of human lymphocytes with mycobacterial antigens.
    Wright EP; Rangarajan R
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):455-7. PubMed ID: 7042608
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
    Reitan LJ; Closs O
    Clin Exp Immunol; 1984 Aug; 57(2):315-23. PubMed ID: 6380833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.
    Aguirre-Blanco AM; Lukey PT; Cliff JM; Dockrell HM
    Infect Immun; 2007 Jun; 75(6):3197-201. PubMed ID: 17387167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG).
    Britton WJ; Garsia RJ; Hellqvist L; Watson JD; Basten A
    Lepr Rev; 1986 Dec; 57 Suppl 2():67-75. PubMed ID: 3553805
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy.
    Melsom R; Naafs B; Harboe M; Closs O
    Lepr Rev; 1978 Mar; 49(1):17-29. PubMed ID: 347205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.